Treatment of Asymptomatic Toxocariasis With Albendazole in Children

Toxocariasis Clinical Trial

Official title: Treatment of Asymptomatic Toxocariasis With Albendazole in Children. A Prospective, Randomized, Placebo-controlled Clinical Trial

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to evaluate effectiveness of albendazole in the treatment of the asymptomatic infection with the parasite Toxocara in children. Treatment response is defined as a reduction in the number of eosinophils in blood. The study drug will be compared to placebo and randomly assigned in a double blind manner. Follow up will be prospective. 50 children (25 per group) will be enrolled in the study.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Toxocariasis

• NCT number: NCT00755560
• Study type: Interventional
• Source: Hospital de Niños R. Gutierrez de Buenos Aires
• Status: Active, not recruiting
• Phase: Phase 3
• Start date: September 2008
• Completion date: July 2025